Abstract
Background: Rolling of leukocytes at the surface of the vascular endothelium is a prerequisite for a subsequent firm adhesion, particularly the slow rolling appearing on ELAM CD62E. Therefore, it may be considered that increasing the rolling velocities should be a precise therapeutic target in clinical situations where leukocytes accumulate, mainly venous and arterial ischaemia.
Methods: Human neutrophils were allowed to flow on endothelial HUVECs, with and without 4 hours interleukin‐1α activation, the cells having or not been incubated with INO5042 anti‐inflammatory drug. Under a mean shear‐stress of 2 dyn/cm2, rollers and stickers were identified and quantified, using a video‐camera and picture analysing software.
Results: When the drug had been added to endothelial cells a shift of velocities was observed towards fast speeds (from 3–5 to 7–11 μm/sec). The same results was significantly found when neutrophils, alone or along with endothelium, had been submitted to the drug, the number of stickers and rollers beeing reduced as well. Finally, such a precise pharmacological method proved efficient to detect the exact mechanism of INO5042 on white cell adhesion.